Australian Influenza Surveillance Report - No 08 - fortnight ending 17 July 2022

The Australian Influenza Surveillance Report and Activity Updates are compiled from a number of data sources, which are used to monitor influenza activity and severity in the community. These data sources include laboratory-confirmed notifications to NNDSS; influenza associated hospitalisations; sentinel influenza-like illness (ILI) reporting from general practitioners; ILI-related community level surveys; and sentinel laboratory testing results.

Page last updated: 22 July 2022

The Australian Influenza Surveillance Report is published on a fortnightly basis during the influenza season, typically between May and October. Influenza activity updates will be published outside of the seasonal period.

Australian Influenza Surveillance Report No 08- fortnight ending 17 July 2022

Key Messages

It is important to note that due to the COVID-19 epidemic in Australia, data reported from the various influenza surveillance systems may not represent an accurate reflection of influenza activity. Results should be interpreted with caution, especially where comparisons are made to previous influenza seasons. Interpretation of 2020 influenza activity data should take into account, but are not limited to, the impact of social distancing measures, likely changes in health seeking behaviour of the community including access to alternative streams of acute respiratory infection specific health services, and focussed testing for COVID-19 response activities. Current COVID-19 related public health measures and the community’s adherence to public health messages are also likely having an effect on transmission of acute respiratory infections, including influenza.

Activity

  • Influenza-like-illness (ILI) activity in the community to date this year peaked in May and June.
  • In the year to date in 2022, there have been 204,911 notifications reported to the National Notifiable Diseases Surveillance System (NNDSS) in Australia, of which 16,707 notifications had a diagnosis date this fortnight.
  • From mid-April 2022, the weekly number of notifications of laboratory-confirmed influenza reported in Australia has exceeded the 5 year average.

Severity

  • In the year to date, of the 204,911 notifications of laboratory-confirmed influenza, 181 influenza-associated deaths have been notified to the NNDSS.
  • Since commencement of seasonal surveillance in April 2022, there have been 1,489 hospital admissions due to influenza reported across sentinel hospitals sites, of which 6.7% were admitted directly to ICU.

Impact

  • There is no indication of the potential impact of the 2022 season on society at this time.

At-risk populations

  • In 2022 to date, people aged 5–9 years, children aged younger than 5 years, and people aged 10–19 years have the highest notification rates.

Virology

  • To date, 82.7% of notifications of laboratory-confirmed influenza reported to the NNDSS were influenza A, of which 94.4% were influenza A(unsubtyped), 0.8% were influenza A(H1N1), and 4.7% were influenza A(H3N2). Influenza B accounted for 0.1% of notifications, less than 0.1% were A&B co-infections, and 17.1% were untyped.

Vaccine match and effectiveness

  • Of the 1,668 samples referred to the WHOCC to date, 98.1% of influenza A(H1N1), 92.4% of influenza A(H3N2), and the 4 influenza B/Victoria samples, were characterised as antigenically similar to the corresponding vaccine components.
  • It is too early to assess vaccine match and effectiveness for this season.

Full Report

top of page

Previous Reports and Updates

Annual Reports

Accessibility Issues

Should you encounter issues in accessing the information contained either on this webpage or within the downloadable full reports please email flu (flu@health.gov.au) or contact the Department of Health switchboard on 02 6289 1555 or 1800 020 103.

top of page